As I reported last week, Alvarion (NASDAQ: ALVR) was rumored to have landed a contract with a French mobile carrier for WiMAX deployment. Well, the rumors were true as a deal was announced today. Alvarion signed a deal with French mobile player, Altitude, to supply the nation-wide carrier with Alvarion's Mobile WiMAX™ 4Motion™ solution using the 3.5 GHz frequency band. Research group Broadpoint Capital said in a research note that it estimated the size of the deal to be worth about $4-5 million over two years. Not too shabby.
Alvarion continues to prove that WiMAX is not dead. While Sprint-Nextel (NYSE: S) and Clearwire (NASDAQ: CLWR) decided to call-off a large U.S. deployment, Alvarion continues to win and secure new client relationships around the world, including Europe and emerging markets. BloggingStocks' Aaron Katsman continues to believe that Sprint's announcement was not a death knell for WiMAX, rather a company-specific problem facing Sprint.
It's also interesting to see that Alvarion beat out home-grown favorite, Alcatel Lucent (NYSE: ALU), to win this contract. This contract, while not large in size, has the potential to grow with time, while carriers like Altitude continue to test WiMAX deployments. Alvarion has over 220 ongoing WiMAX deployments around the world, including some 40 mobile WiMAX tests.
Basic Internet connectivity is still a major focus of countries outside the U.S., and WiMAX looks to be the solution of choice for many foreign telecommunication carriers in terms of cost and speed and ease of deployment. Alvarion is a compelling play for investors betting on the viability of global WiMAX deployment.
Zack Miller is the managing editor of IsraelNewsletter.com and a former equity analyst for a leading multinational hedge fund. Disclaimer: Author's fund has a position in ALVR as of 12/11/2007.
Last updated: February 10, 2012: 12:11 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
TheFlyOnTheWall.com Headlines
- Morgans Hotel management to meet with JMP Securities
- JPMorgan management to meet with Sterne Agee
- International Paper, Temple-Inland settle with DOJ over merger
- W.R. Grace management to meet with CL King
- Compuware management to meet with Jefferies
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?


Reader Comments (Page 1 of 1)
12-13-2007 @ 3:28AM
kfir said...
FT announcement is imminent, this one isn't the one!
12-19-2007 @ 2:02PM
Zack Miller said...
You're right, kfir. My bad: http://israelnewsletter.com/2007/12/19/wimax-is-alive-alvarionalvr-inks-tier-1-deal/